Transplant International (Jan 2025)
γδ T Cells’ Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental Models
- Xavier Charmetant,
- Xavier Charmetant,
- Xavier Charmetant,
- Guillaume Rigault,
- Chien-Chia Chen,
- Hannah Kaminski,
- Hannah Kaminski,
- Jonathan Visentin,
- Jonathan Visentin,
- Benjamin Taton,
- Gabriel Marseres,
- Virginie Mathias,
- Alice Koenig,
- Alice Koenig,
- Alice Koenig,
- Thomas Barba,
- Thomas Barba,
- Thomas Barba,
- Pierre Merville,
- Pierre Merville,
- Stéphanie Graff-Dubois,
- Emmanuel Morelon,
- Emmanuel Morelon,
- Emmanuel Morelon,
- Julie Déchanet-Merville,
- Valérie Dubois,
- Jean-Paul Duong van Huyen,
- Lionel Couzi,
- Lionel Couzi,
- Olivier Thaunat,
- Olivier Thaunat,
- Olivier Thaunat
Affiliations
- Xavier Charmetant
- Centre International de Recherche en Infectiologie, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France
- Xavier Charmetant
- Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
- Xavier Charmetant
- Lyon-Est Faculty of Medicine, Claude Bernard University (Lyon 1), Villeurbanne, France
- Guillaume Rigault
- Centre International de Recherche en Infectiologie, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France
- Chien-Chia Chen
- Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
- Hannah Kaminski
- Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France
- Hannah Kaminski
- ImmunoConcEpT, CNRS, Université de Bordeaux, UMR 5164, Bordeaux, France
- Jonathan Visentin
- ImmunoConcEpT, CNRS, Université de Bordeaux, UMR 5164, Bordeaux, France
- Jonathan Visentin
- Laboratory of Immunology et Immunogenetics, Pellegrin Hospital, Bordeaux, France
- Benjamin Taton
- Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France
- Gabriel Marseres
- ImmunoConcEpT, CNRS, Université de Bordeaux, UMR 5164, Bordeaux, France
- Virginie Mathias
- French National Blood Service (EFS), HLA Laboratory, Décines, France
- Alice Koenig
- Centre International de Recherche en Infectiologie, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France
- Alice Koenig
- Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
- Alice Koenig
- Lyon-Est Faculty of Medicine, Claude Bernard University (Lyon 1), Villeurbanne, France
- Thomas Barba
- Centre International de Recherche en Infectiologie, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France
- Thomas Barba
- Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
- Thomas Barba
- Department of Internal Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
- Pierre Merville
- Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France
- Pierre Merville
- ImmunoConcEpT, CNRS, Université de Bordeaux, UMR 5164, Bordeaux, France
- Stéphanie Graff-Dubois
- 0Sorbonne Université, INSERM, UMRS 959, Immunology-Immunopathology-Immunotherapy (i3), Paris, France
- Emmanuel Morelon
- Centre International de Recherche en Infectiologie, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France
- Emmanuel Morelon
- Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
- Emmanuel Morelon
- Lyon-Est Faculty of Medicine, Claude Bernard University (Lyon 1), Villeurbanne, France
- Julie Déchanet-Merville
- ImmunoConcEpT, CNRS, Université de Bordeaux, UMR 5164, Bordeaux, France
- Valérie Dubois
- French National Blood Service (EFS), HLA Laboratory, Décines, France
- Jean-Paul Duong van Huyen
- 1Pathology Department, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
- Lionel Couzi
- Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France
- Lionel Couzi
- ImmunoConcEpT, CNRS, Université de Bordeaux, UMR 5164, Bordeaux, France
- Olivier Thaunat
- Centre International de Recherche en Infectiologie, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France
- Olivier Thaunat
- Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
- Olivier Thaunat
- Lyon-Est Faculty of Medicine, Claude Bernard University (Lyon 1), Villeurbanne, France
- DOI
- https://doi.org/10.3389/ti.2025.12859
- Journal volume & issue
-
Vol. 38
Abstract
The generation of donor-specific antibodies (DSA) requires that alloreactive B cells receive help from follicular helper T (TFH) cells. Recent works have suggested that γδ T cells could contribute to T cell-dependent humoral responses, leading us to investigate their role in DSA generation. Analysis of a cohort of 331 kidney transplant recipients found no relation between the number of circulating γδ T cells and the risk to develop DSA. Coculture models demonstrated that activated γδ T cells were unable to promote the differentiation of B cells into plasma cells, ruling out that they can be “surrogate” TFH. In line with this, γδ T cells preferentially localized outside the B cell follicles, in the T cell area of lymph nodes, suggesting that they could instead act as “antigen-presenting cell” (APC) to prime αβ TFH. This hypothesis was proven wrong since γδ T cells failed to acquire APC functions in vitro. These findings were validated in vivo by the demonstration that following transplantation with an allogeneic Balb/c (H2d) heart, wild-type and TCRδKO C57BL/6 (H2b) mice developed similar DSA responses, whereas TCRαKO recipients did not develop DSA. We concluded that the generation of DSA is unfazed by the absence of γδ T cells.
Keywords